New drug delivery systems for cytotoxic drugs
JP. Benoit - INSERM U 646, Angers University, France
Consequencies of new drug delivery systems for preparation in hospital pharmacies
F. Lagarce - INSERM U 646, Angers University, France
Assessment of biological exposure with cytotoxic drugs of hospital workers
S. Ndaw - INRS, Vandoeuvre, France
Water pollution with cytotoxic drugs in hospital effluents
S. Zini - Agence Française de Sécurité Sanitaire de l’Environnement et du Travail (AFSSET), France
External vial contamination with cytotoxic drugs : spreading off simulation
G. Podilsky - CHUV Lausanne, Switzerland
Classification of hazardous drugs by NIOSH
T. Connor - National Institute for Occupational Safety and Health, Cincinnati, USA
Assessing the risk of handling monoclonal antibodies
S. Langford - Huddersfield Royal Infirmary, Huddersfield, RU
Standardized method to evaluate occupational risk and protective measures
F. Sadeghipour - HUG, Genève, Switzerland
Objectives and strategy
P. Bonnabry - HUG, Genève, Switzerland
CIVAS : current UK practice and challenges
A. Horton, Plymouth Hospitals, Plymouth, UK
CIVAS and freezing
JD. Hecq - UCL Mont Godinne, Belgium